Macrogenics (MGNX) Enterprise Value (2012 - 2026)

Macrogenics (MGNX) has 15 years of Enterprise Value data on file, last reported at -$66.5 million in Q1 2026.

• Enterprise Value for Q1 2026 came in at -$66.5 million, up 54.31% year-over-year; the trailing twelve-month figure through Mar 2026 was -$66.5 million (up 54.31% YoY), and the FY2025 annual result was -$57.2 million, up 68.71% from the prior year.
• Enterprise Value slipped to -$66.5 million in Q1 2026 per MGNX's latest filing, from -$57.2 million in the prior quarter.
• Over five years, Enterprise Value peaked at -$21.5 million in Q2 2022 and troughed at -$224.3 million in Q1 2023.
• A 5-year average of -$105.4 million and a median of -$89.9 million in 2023 frame the typical range for Enterprise Value.
• The sharpest annual moves came in 2022 and 2023: Enterprise Value jumped 88.64% in 2022, then plunged 406.58% in 2023.
• A 5-year view of Enterprise Value shows it stood at -$108.9 million in 2022, then grew by 7.28% to -$101.0 million in 2023, then tumbled by 81.11% to -$182.8 million in 2024, then surged by 68.71% to -$57.2 million in 2025, then dropped by 16.25% to -$66.5 million in 2026.
• Business Quant data shows MGNX's Enterprise Value at -$66.5 million in Q1 2026, -$57.2 million in Q4 2025, and -$80.1 million in Q3 2025.